Esther González Cantalapiedra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Esther González Cantalapiedra has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Joaquín Pastor
Experimental Therapeutics Programme, Spanish National Cancer Research Centre (CNIO), C/Melchor Fernández Almagro 3, E-28029 Madrid, Spain
4 shared publications - Antonio Cebriá
Experimental Therapeutics Programme, Spanish National Cancer Research Centre (CNIO), C/Melchor Fernández Almagro 3, E-28029 Madrid, Spain
3 shared publications - Antonio M. Echavarren
Institute of Chemical Research of Catalonia (ICIQ)
3 shared publications - Carmen Blanco-Aparicio
Experimental Therapeutics Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain
3 shared publications David Cebrián
Experimental Therapeutics Programme, Spanish National Cancer Research Centre (CNIO), C/ Melchor Fernández Almagro 3, E-28029, Madrid, Spain
3 shared publications- María Isabel Albarrán
Experimental Therapeutics Programme, Spanish National Cancer Research Centre (CNIO), C/Melchor Fernández Almagro 3, E-28029 Madrid, Spain
3 shared publications
Latest Publications
- 1 November 2021
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 224, 113703
Corrigendum to <’ Omipalisib inspired macrocycles as dual PI3K/mTOR inhibitors’ [Eur. J. Med. Chem. 211 (2021), 113109]
- 1 November 2021
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 224, 113703
Corrigendum to <’ Omipalisib inspired macrocycles as dual PI3K/mTOR inhibitors’ [Eur. J. Med. Chem. 211 (2021), 113109]
- 1 April 2019
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 168, 87-109
Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors
- 1 April 2019
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 168, 87-109
Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors
- 1 June 2017
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 27 (11) , 2536-2543
Generation of tricyclic imidazo[1,2- a ]pyrazines as novel PI3K inhibitors by application of a conformational restriction strategy
- 1 June 2017
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 27 (11) , 2536-2543
Generation of tricyclic imidazo[1,2- a ]pyrazines as novel PI3K inhibitors by application of a conformational restriction strategy
- Open Access
- 2 May 2016
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2016 (19) , 3171-3176
Synthesis of a Crushed Fullerene C60H24 through Sixfold Palladium‐Catalyzed Arylation
The synthesis of a new C3v‐symmetric crushed fullerene C60H24 (5) has been accomplished in three steps from truxene through sixfold palladium‐catalyzed intramolecular arylation of a syn‐trialkylated truxene precursor. Laser irradiation of 5 induces cyclodehydrogenation processes that result in the formation of C60, as detected by LDI‐MS.
- 2 May 2016
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2016 (19) , 3171-3176
Open AccessSynthesis of a Crushed Fullerene C60H24 through Sixfold Palladium‐Catalyzed Arylation
The synthesis of a new C3v‐symmetric crushed fullerene C60H24 (5) has been accomplished in three steps from truxene through sixfold palladium‐catalyzed intramolecular arylation of a syn‐trialkylated truxene precursor. Laser irradiation of 5 induces cyclodehydrogenation processes that result in the formation of C60, as detected by LDI‐MS.
- Open Access
- 11 November 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (11) , e112148
PIM Kinases as Potential Therapeutic Targets in a Subset of Peripheral T Cell Lymphoma Cases
Currently, there is no efficient therapy for patients with peripheral T cell lymphoma (PTCL). The Proviral Integration site of Moloney murine leukemia virus (PIM) kinases are important mediators of cell survival. We aimed to determine the therapeutic value of PIM kinases because they are overexpressed in PTCL patients, T cell lines and primary tumoral T cells. PIM kinases were inhibited genetically (using small interfering and short hairpin RNAs) and pharmacologically (mainly with the pan-PIM inhibitor (PIMi) ETP-39010) in a panel of 8 PTCL cell lines. Effects on cell viability, apoptosis, cell cycle, key proteins and gene expression were evaluated. Individual inhibition of each of the PIM genes did not affect PTCL cell survival, partially because of a compensatory mechanism among the three PIM genes. In contrast, pharmacological inhibition of all PIM kinases strongly induced apoptosis in all PTCL cell lines, without cell cycle arrest, in part through the induction of DNA damage. Therefore, pan-PIMi synergized with Cisplatin. Importantly, pharmacological inhibition of PIM reduced primary tumoral T cell viability without affecting normal T cells ex vivo. Since anaplastic large cell lymphoma (ALK+ ALCL) cell lines were the most sensitive to the pan-PIMi, we tested the simultaneous inhibition of ALK and PIM kinases and found a strong synergistic effect in ALK+ ALCL cell lines. Our findings suggest that PIM kinase inhibition could be of therapeutic value in a subset of PTCL, especially when combined with ALK inhibitors, and might be clinically beneficial in ALK+ ALCL.
- 11 November 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (11) , e112148
Open AccessPIM Kinases as Potential Therapeutic Targets in a Subset of Peripheral T Cell Lymphoma Cases
Currently, there is no efficient therapy for patients with peripheral T cell lymphoma (PTCL). The Proviral Integration site of Moloney murine leukemia virus (PIM) kinases are important mediators of cell survival. We aimed to determine the therapeutic value of PIM kinases because they are overexpressed in PTCL patients, T cell lines and primary tumoral T cells. PIM kinases were inhibited genetically (using small interfering and short hairpin RNAs) and pharmacologically (mainly with the pan-PIM inhibitor (PIMi) ETP-39010) in a panel of 8 PTCL cell lines. Effects on cell viability, apoptosis, cell cycle, key proteins and gene expression were evaluated. Individual inhibition of each of the PIM genes did not affect PTCL cell survival, partially because of a compensatory mechanism among the three PIM genes. In contrast, pharmacological inhibition of all PIM kinases strongly induced apoptosis in all PTCL cell lines, without cell cycle arrest, in part through the induction of DNA damage. Therefore, pan-PIMi synergized with Cisplatin. Importantly, pharmacological inhibition of PIM reduced primary tumoral T cell viability without affecting normal T cells ex vivo. Since anaplastic large cell lymphoma (ALK+ ALCL) cell lines were the most sensitive to the pan-PIMi, we tested the simultaneous inhibition of ALK and PIM kinases and found a strong synergistic effect in ALK+ ALCL cell lines. Our findings suggest that PIM kinase inhibition could be of therapeutic value in a subset of PTCL, especially when combined with ALK inhibitors, and might be clinically beneficial in ALK+ ALCL.
- 19 May 2006
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 8 (12) , 2451-2454
Molecular Panels for Energy Transduction in C60-Based Conjugates
Light-harvesting C60-based dyads endowed with a truxene fluorophore unit have been synthesized. Their photophysical studies in solution reveal a singlet−singlet energy transfer deactivation mechanism that confirms the actuation of the latter as an efficient molecular panel for light absorption and energy transduction. Those processes strongly depend on the nature of the linker connecting both chromophores, such as C60 and truxene, owing to the overlapping degree between their respective orbitals.
- 19 May 2006
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 8 (12) , 2451-2454
Molecular Panels for Energy Transduction in C60-Based Conjugates
Light-harvesting C60-based dyads endowed with a truxene fluorophore unit have been synthesized. Their photophysical studies in solution reveal a singlet−singlet energy transfer deactivation mechanism that confirms the actuation of the latter as an efficient molecular panel for light absorption and energy transduction. Those processes strongly depend on the nature of the linker connecting both chromophores, such as C60 and truxene, owing to the overlapping degree between their respective orbitals.
- 28 February 2006
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2006 (6) , 1430-1443
Synthesis of the Benzo[b]fluorene Core of the Kinamycins by Arylalkyne–Allene and Arylalkyne–Alkyne Cycloadditions
Arylalkyne–allene and arylalkyne–alkyne cycloadditions yields benzo[a]fluorenones, which are related to the tetracyclic core of the kinamycins. In the arylalkyne–alkyne cycloadditions, we found a rearrangement that produces benzo[a]fluorenones, in addition to the expected benzo[b]fluorenones. This rearrangement could be suppressed in the presence of phenol, which allowed the synthesis of 4,9‐dimethoxy‐2‐methyl‐11H‐benzo[b]fluoren‐11‐one in excellent yield.(© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2006)
- 28 February 2006
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2006 (6) , 1430-1443
Synthesis of the Benzo[b]fluorene Core of the Kinamycins by Arylalkyne–Allene and Arylalkyne–Alkyne Cycloadditions
Arylalkyne–allene and arylalkyne–alkyne cycloadditions yields benzo[a]fluorenones, which are related to the tetracyclic core of the kinamycins. In the arylalkyne–alkyne cycloadditions, we found a rearrangement that produces benzo[a]fluorenones, in addition to the expected benzo[b]fluorenones. This rearrangement could be suppressed in the presence of phenol, which allowed the synthesis of 4,9‐dimethoxy‐2‐methyl‐11H‐benzo[b]fluoren‐11‐one in excellent yield.(© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2006)
- 13 September 2005
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2005 (19) , 4127-4140
New Building Blocks Based on Truxene Cores: Synthesis of Functionalized syn‐Tri‐ and ‐Hexasubstituted Derivatives
Hexasubstituted truxenes are obtained in one step by alkylation of the potassium anion of truxene. Subsequent derivatization provides truxene derivatives with six carboxy, amino, or hydroxy groups at their peripheries. Alkylation of syn‐5,10,15‐tribenzyl derivatives with a different benzyl bromide derivative affords mixtures of anti‐ and syn‐hexasubstituted truxenes. Truxenes with phenols or benzoquinone groups have also been synthesized by starting from truxenetrione. (© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2005)
- 13 September 2005
- Published by Wiley in European Journal of Organic Chemistry
- Vol. 2005 (19) , 4127-4140
New Building Blocks Based on Truxene Cores: Synthesis of Functionalized syn‐Tri‐ and ‐Hexasubstituted Derivatives
Hexasubstituted truxenes are obtained in one step by alkylation of the potassium anion of truxene. Subsequent derivatization provides truxene derivatives with six carboxy, amino, or hydroxy groups at their peripheries. Alkylation of syn‐5,10,15‐tribenzyl derivatives with a different benzyl bromide derivative affords mixtures of anti‐ and syn‐hexasubstituted truxenes. Truxenes with phenols or benzoquinone groups have also been synthesized by starting from truxenetrione. (© Wiley‐VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2005)
- 7 May 2004
- Published by Wiley in Chemistry – A European Journal
- Vol. 10 (10) , 2601-2608
Synthesis of C3 Benzo[1,2‐e:3,4‐e′:5,6‐e′′]tribenzo[l]acephenanthrylenes (“Crushed Fullerene” Derivatives) by Intramolecular Palladium‐Catalyzed Arylation
The C60 polyarenes 4, 5, 18 a, and 18 b have been synthesized from truxene by triple alkylation at C5, C10, and C15 followed by a palladium‐catalyzed intramolecular arylation. The synthesis of “crushed fullerene” C60H30 (2) is the most efficient reported to date and proceeds in 33 % overall yield.
- 7 May 2004
- Published by Wiley in Chemistry – A European Journal
- Vol. 10 (10) , 2601-2608
Synthesis of C3 Benzo[1,2‐e:3,4‐e′:5,6‐e′′]tribenzo[l]acephenanthrylenes (“Crushed Fullerene” Derivatives) by Intramolecular Palladium‐Catalyzed Arylation
The C60 polyarenes 4, 5, 18 a, and 18 b have been synthesized from truxene by triple alkylation at C5, C10, and C15 followed by a palladium‐catalyzed intramolecular arylation. The synthesis of “crushed fullerene” C60H30 (2) is the most efficient reported to date and proceeds in 33 % overall yield.